Name: BAUSCH + LOMB CORP (BLCO) Stock
Brand: BAUSCH + LOMB CORP
Rating: 5.5 (3 reviews)

BLCO Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

2 months ago - By: Benzinga - Mentions: CGO ROL ESRT NNBR ...

Earnings Scheduled For October 29, 2025

2 months ago - By: Zacks Investment Research - Mentions: DHR

BLCO vs. DHR: Which Stock Should Value Investors Buy Now?

12 days ago - By: The Motley Fool - Mentions: GPOR MSC SATS

BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point?

a month ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb to Participate in Citi Global Healthcare Conference

a month ago - By: New York Stock Exchange - Mentions: TKO

NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership

a month ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

a month ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program

a month ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb to Hold Investor Day on Nov. 13

2 months ago - By: Zacks Investment Research

Bausch + Lomb (BLCO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

2 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Third-Quarter 2025 Results

2 months ago - By: Stocktwits - Mentions: COO

Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

3 months ago - By: Bausch + Lomb Corporation - Mentions: BLCO.CA

BAUSCH + LOMB CORP (BLCO) Stock News

BLCO Latest News, Press Relases and Analysis

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

Earnings Scheduled For October 29, 2025

BLCO vs. DHR: Which Stock Should Value Investors Buy Now?

BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point?

Bausch + Lomb to Participate in Citi Global Healthcare Conference

NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program

Bausch + Lomb to Hold Investor Day on Nov. 13

Bausch + Lomb (BLCO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Bausch + Lomb Announces Third-Quarter 2025 Results

Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report

Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States